文献速递内脏/肾动脉与血管畸形

药物治疗与干预未优于单纯观察改善孤立性肠系膜动脉夹层结局

Medical therapy and intervention do not improve uncomplicated isolated mesenteric artery dissection outcomes over observation alone.
PubMed 文献 · J Vasc Surg · 2017-05-12

多中心回顾性研究纳入227例孤立性腹腔动脉或肠系膜上动脉夹层患者,比较药物治疗、观察及手术/腔内干预的远期结局。无症状患者可观察随访,无缺血症状的症状性患者不必需抗凝,抗血小板或观察即可。

要点

  • 无症状孤立性肠系膜动脉夹层可观察并间歇影像随访。
  • 无缺血证据的症状性患者不必需抗凝,可抗血小板或观察。
  • 症状性患者夹层长度显著长于无症状患者。

核心结论

  • 无症状孤立性肠系膜动脉夹层可观察并间歇影像随访。
  • 无缺血证据的症状性孤立性肠系膜动脉夹层不必需抗凝,可抗血小板或观察。

研究设计与样本

  • 多中心回顾性研究纳入2003年1月至2015年12月共227例腹腔动脉或肠系膜上动脉夹层患者,排除主动脉夹层。

主要发现

  • 平均年龄55±12.5岁,男性82%,有症状162例,无症状65例。
  • 孤立性肠系膜上动脉夹层158例,腹腔动脉夹层81例,两者同时夹层12例。
  • 症状性患者夹层长度显著长于无症状患者:腹腔动脉27 vs 18 mm(P=.01),肠系膜上动脉64 vs 40 mm(P<.001)。
  • 晚期血管血栓形成6例(3%),动脉瘤样变性16例(8%)。
  • 无缺血证据的症状性患者(n=134)药物治疗与观察的晚期血管血栓形成无差异(9% vs 0%;P=.35),动脉瘤样变性无差异(9% vs 5%;P=.95)。

关键数值与推荐

  • 无症状患者(n=64)5年内无晚期血管血栓形成事件。
  • 排除因缺血治疗的患者后,手术干预与药物治疗的晚期血管血栓形成无差异(1 vs 5;P=.57)。
  • 18例接受手术或腔内干预(3例缺血,13例疼痛,1例动脉瘤样变性,1例无症状)。

临床怎么用

  • 无症状孤立性肠系膜动脉夹层可首选观察并间歇影像随访。
  • 无缺血证据的症状性患者可不抗凝,选择抗血小板治疗或观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Isolated dissection of the mesenteric vessels is rare but increasingly recognized. This study aimed to evaluate patient characteristics, primary treatment, and subsequent outcomes of mesenteric dissection using multi-institutional data. METHODS: All patients at participant hospitals between January 2003 and December 2015 with dissection of the celiac artery (or its branches) or dissection of the superior mesenteric artery (SMA) were included. Patients with an aortic dissection were excluded. Demographic, treatment, and follow-up data were collected. The primary outcomes included late vessel thrombosis (LVT) and aneurysmal degeneration (AD). RESULTS: Twelve institutions identified 227 patients (220 with complete treatment records) with a mean age of 55 ± 12.5 years. Median time to last follow up was 15 months (interquartile range, 3.8-32). Most patients were men (82% vs 18% women) and symptomatic at presentation (162 vs 65 asymptomatic). Isolated SMA dissection was more common than celiac artery dissection (n = 158 and 81, respectively). Concomitant dissection of both arteries was rare (n = 12). The mean dissection length was significantly longer in symptomatic patients than in asymptomatic patients in both the celiac artery (27 vs 18 mm; P = .01) and the SMA (64 vs 40 mm; P < .001). Primary treatment was medical in 146 patients with oral anticoagulation or antiplatelet therapy (n = 76 and 70, respectively), whereas 56 patients were observed. LVT occurred in six patients, and 16 patients developed AD (3% and 8%, respectively). For symptomatic patients without evidence of ischemia (n = 134), there was no difference in occurrence of LVT with medical therapy compared with observation alone (9% vs 0%; P = .35). No asymptomatic patient (n = 64) had an episode of LVT at 5 years. AD rates did not differ among symptomatic patients without ischemia treated with medical therapy or observed (9% vs 5%; P = .95). Surgical or endovascular intervention was performed in 18 patients (3 ischemia, 13 pain, 1 AD, 1 asymptomatic). Excluding the patients treated for ischemia, there was no difference in LVT with surgical intervention vs medical management (one vs five; P = .57). CONCLUSIONS: Asymptomatic patients with isolated mesenteric artery dissection may be observed and followed up with intermittent imaging. Symptomatic patients tend to have longer dissections than asymptomatic patients. Symptomatic isolated mesenteric artery dissection without evidence of ischemia does not require anticoagulation and may be treated with antiplatelet therapy or observation alone.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Loeffler JW, Obara H, Fujimura N, et al. Medical therapy and intervention do not improve uncomplicated isolated mesenteric artery dissection outcomes over observation alone. J Vasc Surg. 2017. PMID: 28506477. doi:10.1016/j.jvs.2017.01.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。